CAPITOL COUNSEL LLC for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of Medicare pharmaceutical coverage and reimbursement, 340B Program, Medicare Part B reimbursement for physicians, and related provisions of the Affordable Care Act. Reimbursement adequacy and patient access issues associated with potential CMMI implementation of the proposed Medicare Part B Drug Payment Model.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE ABRAMSON | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JAMES O MCCRERY | — |
| JOHN D RAFFAELLI | — |
Health Issues HCR
Monitor implementation of the National Cancer Moonshot Initiative.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE ABRAMSON | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JAMES O MCCRERY | — |
| JOHN D RAFFAELLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.